ArTS Archivio della ricerca di Trieste

BENUSSI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.189
NA - Nord America 3.665
EU - Europa 2.281
SA - Sud America 1.171
AF - Africa 132
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.453
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.477
SG - Singapore 1.602
IT - Italia 1.122
CN - Cina 1.034
BR - Brasile 892
VN - Vietnam 660
BD - Bangladesh 573
KR - Corea 501
HK - Hong Kong 403
NL - Olanda 194
FR - Francia 181
PL - Polonia 148
GB - Regno Unito 123
DE - Germania 113
AR - Argentina 112
FI - Finlandia 109
RU - Federazione Russa 100
CA - Canada 80
IN - India 68
MX - Messico 66
ID - Indonesia 54
EC - Ecuador 48
JP - Giappone 37
ZA - Sudafrica 37
IQ - Iraq 36
ES - Italia 31
PK - Pakistan 31
SE - Svezia 31
CO - Colombia 26
PY - Paraguay 25
SA - Arabia Saudita 25
TR - Turchia 25
UA - Ucraina 21
MA - Marocco 20
UZ - Uzbekistan 20
AT - Austria 18
VE - Venezuela 18
PE - Perù 17
CL - Cile 15
KE - Kenya 14
PH - Filippine 14
CH - Svizzera 13
IR - Iran 13
AE - Emirati Arabi Uniti 11
AU - Australia 10
BO - Bolivia 10
EG - Egitto 10
JM - Giamaica 10
NP - Nepal 10
DZ - Algeria 9
IE - Irlanda 9
JO - Giordania 9
DO - Repubblica Dominicana 8
TW - Taiwan 8
UY - Uruguay 8
DK - Danimarca 7
KZ - Kazakistan 7
AZ - Azerbaigian 6
GN - Guinea 6
LB - Libano 6
OM - Oman 6
PT - Portogallo 6
SV - El Salvador 6
AL - Albania 5
BE - Belgio 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
GR - Grecia 5
MY - Malesia 5
RS - Serbia 5
TH - Thailandia 5
XK - ???statistics.table.value.countryCode.XK??? 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
LT - Lituania 4
NG - Nigeria 4
TN - Tunisia 4
BH - Bahrain 3
CG - Congo 3
KW - Kuwait 3
LU - Lussemburgo 3
LV - Lettonia 3
RO - Romania 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
MD - Moldavia 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SC - Seychelles 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
Totale 12.427
Salva come PNG Salva come JPEG
Città #
Singapore 830
Hefei 576
San Jose 543
Ashburn 521
Seoul 500
Hong Kong 396
Chicago 325
Ho Chi Minh City 257
Boardman 206
Trieste 202
Los Angeles 191
Beijing 164
Hanoi 139
Milan 132
Council Bluffs 125
Zgierz 114
Lauterbourg 106
New York 95
Salt Lake City 92
Buffalo 83
Dallas 83
São Paulo 80
London 77
Helsinki 74
Rome 66
Frankfurt am Main 45
Santa Clara 41
Moscow 40
Tampa 39
Elk Grove Village 38
Rio de Janeiro 32
The Dalles 32
Lappeenranta 25
Miano 25
Mexico City 24
Tokyo 24
Haiphong 23
Lancaster 23
Orem 23
Atlanta 22
Naples 22
Da Nang 21
Redondo Beach 20
Toronto 20
Montreal 19
Warsaw 19
Guayaquil 18
Johannesburg 18
San Francisco 18
Turin 18
Curitiba 17
Houston 17
Sterling 17
Tashkent 17
Genoa 16
Salvador 16
Buenos Aires 15
Casablanca 15
Florence 15
Munich 15
Thái Bình 15
Brasília 14
Nuremberg 14
Phoenix 14
Tianjin 14
Washington 14
Belo Horizonte 13
Bologna 13
Brooklyn 13
Charlotte 13
Dulles 13
Miami 13
Porto Alegre 13
Amsterdam 12
Guangzhou 12
Jakarta 12
Jeddah 12
Kansas City 12
Seattle 12
Wilmington 12
Bari 11
Biên Hòa 11
Detroit 11
Hải Dương 11
Lima 11
Nairobi 11
Recife 11
Tehran 11
Campinas 10
Dhaka 10
Hangzhou 10
Lahore 10
New Delhi 10
Pittsburgh 10
Quito 10
Vienna 10
Boston 9
Dublin 9
Fortaleza 9
Guarulhos 9
Totale 7.250
Salva come PNG Salva come JPEG
Nome #
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 324
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 281
New insights into the genetic etiology of Alzheimer's disease and related dementias 213
Angiopatia amiloide cerebrale e occlusione dell’auricola sinistra: evidenze e possibili linee operative per un approccio collaborativo fra Cardiologia e Neurologia 203
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis 191
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 170
Alpha rhythm and Alzheimer's disease: Has Hans Berger's dream come true? 167
Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia 161
The role of parvalbumin interneuron dysfunction across neurodegenerative dementias 152
Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers 142
Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features 139
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes 137
Clinical characteristics and management of functional neurological disorders (FND) mimicking stroke in emergency settings: a functional stroke mimic cases 134
A novel CSF1R mutation mimicking frontotemporal dementia: A glimpse into a microgliopathy 133
Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease 132
Targeting Neural Oscillations for Cognitive Enhancement in Alzheimer's Disease 131
Diagnostic performance of plasma pTau217/Aβ42 ratio and a three-zone threshold model for Alzheimer's disease 126
Assessing frailty at the centers for dementia and cognitive decline in Italy: potential implications for improving care of older people living with dementia 125
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 119
Advances in the treatment and management of frontotemporal dementia 119
Aberrant origin of the occipital artery from the internal carotid artery: utility of the occipital tap maneuver 117
Cortico-spinal tDCS in amyotrophic lateral sclerosis: A randomized, double-blind, sham-controlled trial followed by an open-label phase 117
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 113
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes 112
Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum 109
Alpha tACS Improves Cognition and Modulates Neurotransmission in Dementia with Lewy Bodies 109
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer's Disease: A Six-Month, Open-Label, Observational Study 108
Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network 106
Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort 103
TMS for staging and predicting functional decline in frontotemporal dementia 101
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 100
The emerging field of non-invasive brain stimulation in Alzheimer's disease 99
"Real-world" eligibility for aducanumab depends on clinical setting and patients' journey 98
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 96
The role of insulin resistance and APOE genotype on blood-brain barrier integrity in Alzheimer's disease 96
NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features 95
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy 94
State-of-the-art methods and emerging fluid biomarkers in the diagnostics of dementia—a short review and diagnostic algorithm 93
Sex influences clinical phenotype in frontotemporal dementia 93
Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia 93
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 92
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 92
Brain Stimulation in Alzheimer's Disease Trials 92
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 92
Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study 91
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 91
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 89
Immune Effector Cell-Associated Neurotoxicity Delayed Relapse After Chimeric Antigen Receptor T-Cell Therapy: A Case Report 89
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 89
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 88
Plasma p-tau217 and neurofilament/p-tau217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration 87
Differential early subcortical involvement in genetic FTD within the GENFI cohort 86
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 86
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 85
Differences and similarities between familial and sporadic frontotemporal dementia: An Italian single-center cohort study 85
Neurophysiological correlates of altered time awareness in Alzheimer’s disease and frontotemporal dementia 83
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 83
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 83
The Therapeutic Potential of Non-Invasive and Invasive Cerebellar Stimulation Techniques in Hereditary Ataxias 83
Towards a new Value-based scenario for the management of dementia in Italy: a SINdem delphi consensus study 82
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 82
Non-invasive cerebellar stimulation in neurodegenerative ataxia: A literature review 80
Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial 80
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 79
Cortical Inhibitory Imbalance in Functional Paralysis 79
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 79
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 78
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 77
Patients with Alzheimer’s disease dementia show partially preserved parietal ‘hubs’ modeled from resting-state alpha electroencephalographic rhythms 77
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 76
Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia 76
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 76
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 75
Defining the Role of Frailty in the Transition from Mild Cognitive Impairment to Dementia and in Dementia Progression 75
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 75
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 74
COVID-19 impact on consecutive neurological patients admitted to the emergency department 74
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 74
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study 73
Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia 73
Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia 72
Serum neurofilament light in professional soccer players: goal on safety 72
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 71
Cortical network modularity changes along the course of frontotemporal and Alzheimer's dementing diseases 70
Non-Invasive Brain Stimulation for Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives 69
Comparing Cerebellar tDCS and Cerebellar tACS in Neurodegenerative Ataxias Using Wearable Sensors: A Randomized, Double-Blind, Sham-Controlled, Triple-Crossover Trial 69
Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer's disease and frontotemporal lobar degeneration 69
Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias 69
Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study 68
Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design 68
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort 68
The Effect of Coil Orientation on the Stimulation of the Pre–Supplementary Motor Area: A Combined TMS and EEG Study 68
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 67
GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice 67
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 66
Longitudinal Cognitive Changes in Genetic Frontotemporal Dementia Within the GENFI Cohort 66
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 65
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 65
Transcranial Magnetic Stimulation Across the Lifespan: Impact of Developmental and Degenerative Processes 65
Experimental disease-modifying agents for frontotemporal lobar degeneration 65
Totale 9.990
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.136 0 0 13 139 352 248 325 91 105 236 150 477
2025/202610.800 1.291 887 995 1.374 523 641 947 365 884 1.223 949 721
Totale 12.936